Single-cell RNA-seq has emerged as a powerful method to unravel heterogeneity of complex biological systems; this has enabled in vivo characterization of cell type compositions through unsupervised sampling and modelling of transcriptional states in single cells. Here we used the high-throughput microfluidic- In conclusion, our study recapitulates developmental mechanisms that have gone awry during carcinogenesis in a model of PABC. We provide a large-scale single-cell transcriptional landscape of breast tumours that allows unprecedented understanding of breast heterogeneity and deep analysis of key molecular events that result in cancer malignancy.
Abstract
Single-cell RNA-seq has emerged as a powerful method to unravel In conclusion, our study recapitulates developmental mechanisms that have gone awry during carcinogenesis in a model of PABC. We provide a large-scale single-cell transcriptional landscape of breast tumours that allows unprecedented understanding of breast heterogeneity and deep analysis of key molecular events that result in cancer malignancy.
Introduction
The mammary gland is a unique organ that undergoes a series of developmental processes that mostly occur postnatally, reaching its functional secretory capacity after puberty 1 . In its adult form, the mammary gland is mainly formed of an epithelial ductal tree surrounded by the fat pad, a structure rich in adipocytes and fibroblasts that serves as a scaffold 2, 3 . The mammary epithelium is highly dynamic and its hierarchical structure varies in response to physiological factors 4 and the local paracrine factors within the tissue microenvironment (TME) [5] [6] [7] [8] [9] [10] . Such dynamic hierarchical structure is underpinned by a number of intermediate progenitors and cells with pluripotent capacity (reviewed in 11, 12 , however the existence of unipotent or bipotent stem cells and their identity is still controversial [13] [14] [15] [16] [17] [18] [19] [20] [21] The developmental stages that take place during pregnancy, lactation and involution are the most intense and result in extensive changed in tissue morphogenesis 11 . During pregnancy the mammary gland undergoes extensive gland maturation and alveologenesis in preparation for lactation; this is characterised by epithelial cell proliferation and differentiation into alveolar milk-secretory cells, followed by the replacement of the interstitial adipose tissue with alveolar cells and an increase in vascularisation. Adipocytes, fibroblasts and endothelium are thus reorganised to support the newly formed epithelium and the intensive metabolic demand of milk production 1 . The immune system is also intimately involved during pregnancy, participating in ductal branching and epithelial invasion through the fatpad 1 . In preparation for lactation, at the second half of pregnancy, Prl induces the upregulation of Elf5, the master transcriptional regulator of alveolar cell fate 22, 23 , and other factors involved in milk production and mammary gland remodelling such as, Stat5 [24] [25] [26] and Gata-3 [27] [28] [29] . The expression of Elf5 orchestrates the differentiation of the CD61+ luminal progenitor cells (also EpCAM high /Sca1 + /CD49b + , 12 ) towards the CD61-alveolar differentiated population developing epithelial-like properties and polarisation and that ultimately result in the acquisition of secretory properties 11, 23 .
Mammary involution is also a highly complex multicellular process that occurs upon weaning when the lactating mammary gland returns to a quasi-nulliparous state 1, 30 ; it can be divided into two stages, the first one is characterised by intense apoptosis of the secretory alveolar cells, and the second phase is governed by tissue remodelling, mediated by stromal fibroblasts and immune cells, and adipogenesis. In the involuting mammary gland, neutrophils and macrophages are in charge of cleaning the apoptotic bodies of the collapsing alveoli as well as regulating inflammation by suppressing the adaptive immune response. Fibroblasts are also activated during involution to fill the areas left by the dying epithelium in a pseudowound healing process 31 . Thus, the exquisitely regulated morphogenesis of the mammary gland implies a high degree of cell-to-cell communication within the mammary epithelium but also throughout a vast array of cell types from the tissue microenvironment.
One of the most active areas of research in the last years has been the study of the contribution of normal process during mammary gland development to breast cancer. The different epithelial cell lineages of the mammary gland have been associated with the cell of origin of the breast cancer subtypes 32, 33 , including those with specific genetic aberrations 33, 34 . Furthermore, the association of developmental cues within breast cancer is not restricted to the epithelial compartment, as tissue morphogenesis encompasses dramatic changes within the epithelial ductal tree as well as its surrounding stroma. Importantly, pregnancy-associated breast cancer (PABC) is correlated with metastatic disease and poor prognosis (reviewed in 35 ) . One of the possible reasons for the higher mortality in PABC is the effects of the hormonal load associated with the onset of pregnancy, however there is increasing evidence pointing to a direct effect of the TME and the events of tissue remodelling that occur in the mammary gland during pregnancy, in particular those associated to involution, as the driving force behind PABC 31, 35, 36 . In this context, we have previously shown that pregnancy-associated transcriptional networks driven by Elf5 promote a lethal phenotype in breast cancer, including resistance to therapy 37 and promotion of metastatic disease 38 . Elf5 profoundly affects cell intrinsic properties of breast cancer cells but it also heavily alters the TME dramatically increasing metastasis formation.
Here we use our pregnancy-associated breast cancer pre-clinical model of Elf5 overexpression in the MMTV/PyMT mice to study tumour heterogeneity at single- Lastly, we describe the cell to cell interactions in tumours from all cellular compartments. We find two particular cancer-associated fibroblast (CAF)
subpopulations with features of involuting mammary fibroblasts that are dominantly presented in Elf5 tumours and suggest a crosstalk between cancer epithelial cells and
CAFs to promote features of involution in breast cancer.
Materials and Methods

Animal statement, doxycycline induction
To promote tumour progression, ELF5 expression was specifically induced in mammary epithelial cells since puberty (6 weeks-old) through doxycycline containing food as performed previously 38 . At ethical endpoint (7-13% tumour/body weight) mice were euthanized and tumours harvested and processed for single cell digestions as previously performed 38 .
Tumour digestion and FACS
Mammary tumours were collected from MMTV-PyMT mice at 14 weeks of age, when tumour weights were 10±3% of total weight. Areas of necrosis were excluded and only regions of epithelial mammary carcinomas were used for digestion and analysis. Tumours were manually dissected into 3-5mm pieces using a surgical scalpel blade before being chopped to 100µm with maximum blade force on a for 5min at 4 o C between each step. The supernatant was aspirated and 1mg/mL DNase (Roche) was mixed with the sample before incubation with each step. Finally, cells were filtered through a 40µM nylon mesh (Corning) and resuspended in PBS with 2% FBS. FACS was performed as detailed in 37, 38 . Briefly, cells were sorted on the FACSAriaIII (Becton Dickinson) following automated compensation (FACSDiVa) using a 100um nozzle. Cell were sorted using a purity mask to ensure purities of the sorted population in excess of 99%. Antibodies with conjugated fluorophores for sorting stromal cells used included CD140b (clone REA634) from MACS (Miltenyi Biotech), CD140a (clone APA5) from Biolegend, and CD34 (clone RAM34) from BD Pharmingen.
Auto macs cleanup
The viability of the cells was assessed by FACS. All tumours that contained less than 80% viable cells were labelled with Annexin specific MACS beads and dead cells were removed by passing the labelled cells through the autoMACS® Pro (Miltenyi).
Highly viable cells (>85% viability assessed by DAPI in FACS) were loaded into the microfluidic Drop-seq pipeline.
Drop-seq
Cells were captured using the microfluidic devices described for Dropseq 39 
Bioinformatic analysis
The sequencing output was analysed using the McCaroll lab cookbook a custom genome (mm10 plus Trinity assemblies of transgene sequences 40 ) and gene annotation (gencode vM14 plus). Seurat (v Seurat_2.3.4 41 ) was the main platform for downstream analysis.
Firstly, we removed low-quality cells by modelling mitochondrial to nuclear gene content to <15% 39 and considering differences between homeostatic tissues and tumours (SuppFig. 1). We subsequently removed outlier cells that contained more than 4,000 genes as they could potentially constitute cell doublets. Thus, in summary, DGE matrices were trimmed for quality metrics (>200 genes, <15% mitochondrial reads, <1200 UMI and genes expressed in at least 3 cells).
These genes were organised into principal components that defined the variation in gene expression among our samples, SuppFig. fibres (as a % of total fibres) was calculated.
Hypoxia analysis
Tumours and lungs were harvested and fixed in 10% neutral-buffered formalin overnight. FFPE tissues were sectioned to 4µm for IHC staining as described in 38 .
Following the manufacturer's instructions, the FITC-conjugated pimonidazole primary antibody (Hypoxyprobe, 1:1000) and the anti-FITC secondary antibody (Hypoxyprobe 1:100) was used to stain for the pimonidazole adducts. Quantification of hypoxia in IHC was performed using Andy's DAB Algorithm 52 .
Mammary gland whole mounting and immunohistochemistry
Mouse mammary glands from FVB/N mice with established lactation and mammary tumours from PyMT/WT and PyMT/ELF5 were fixed, defatted, dehydrated and carmine stained and paraffin embedded as previously described 53 . Sections were stained with haematoxylin and eosin and with a mouse milk specific protein antibody (Accurate Chemical & Scientific CO, Cat #YNRMMSP) under conditions previously described 53 .
Western Blot and Immunohistochemistry
Western Blot analyses of protein were performed as previously detailed in 37 . The primary antibodies not described in Kalyuga et al were used as follows: E-Cadherin (BD bioscience #610181, 1:10,000) and Vimentin (Leica Biosystems # VIM-572-L-CE).
Mouse mammary glands and tumours from PyMT mice were fixed, defatted, dehydrated, stained in Carmine alum and Paraffin embedded as previously described 53 . Sections were stained with the rabbit anti-mouse milk proteins antibody (Accurate Chemical & Scientific CO, # YNRMTM) diluted 1:12,000 as per 53 .
Results
Unbiased high-resolution scRNAseq captures cell heterogeneity of MMTV-
PyMT mammary tumours.
Fifteen MMTV-PyMT mouse mammary tumours were harvested and analysed using Drop-seq, eight tumours from MMTV-PyMT/WT mice (PyMT/WT) and seven tumours from MMTV-PyMT/ELF5 (PyMT/ELF5) mice ( Fig 1A) . We Drop-seq- We used the dispersion and robustness of gene expression to define 6,176
informative genes in our data set that showed differences in expression level.
Amongst these genes we identified typical marker genes of the three main cell compartments of PyMT tumours, namely epithelium, stroma and immune ( replicates contributed to all cell clusters (SuppFig. 3A) indicating that the defined principal components were not driven by technical batch effects; rather induction of ELF5 expression was the major driver of diversity in variation of gene expression, we found a strong east-west polarisation in the main cluster driven by forced ELF5 expression (cluster I, SuppFig. 3B), however this effect was not observed in the smaller cell clusters (II-VII, SuppFig. 3B).
We identified the presence of the main cellular compartments in the tumours using cell signatures defined by Aran and colleagues, 54 ( Fig. 1C ). This analysis was of epithelial origin and thus the polarisation effect derived from forced Elf5 expression was confined to the epithelial cell compartment. We confirmed the identification of these three major cellular components using the expression of canonical markers for each compartment (Fig. 1D ).
We then used differential gene expression analysis and k-means clustering to identify cell lineages within these major cell classes ( Fig PyMT cancer cells are organised in a structure that resembles the mammary gland epithelial hierarchy.
In our Drop-seq analysis, the major difference between genotypes was confined to the epithelial cell compartment. Thus, we performed an independent clustering on the epithelial subset cohort of cells (6475 PyMT/WT and 3233
PyMT/Elf5 cells) at an increased resolution ( Fig. 3 ). Epithelial tumour cells were distributed in 11 clusters ( Figure 3A and SupplFig 4B). Figure 3B shows the strong genotype-driven cell polarisation in the epithelial compartment, which was not due to batch effects (SuppFig. 5 and Extended Methods). The tSNE plot from Figure 3B shows that clusters 1 and 6 were formed mostly in response to forced ELF5 Fig 3C) .
We used the gene expression signatures defining the major epithelial cell lineages of the normal mammary gland 44 to determine which cell lineages best represented our MMTV-PyMT epithelial cell clusters. Ternary plots shown in SuppFig. 6A revealed that most clusters fell closest to the luminal progenitor corner, but clusters 7 and 8 were located towards the basal region while cluster 10 and a portion of the cells that belonged to cluster 9 were located towards the ML signature.
Importantly, Cluster 10 showed very low levels of the PyMT oncogene ( Fig. 3B bottom violin plot), suggesting that this cluster could be formed of untransformed normal cells that were trapped within the mass of the tumours, this hypothesis is consistent with the small number of cells that belonged to this cluster. To increase the definition provided by these signatures we also annotated PyMT clusters using the mammary epithelial lineage markers defined by Bach and cols. 55 ( Fig. 3D) . 
Dynamic relationship and states of the malignant lineages of PyMT tumours:
implications for the cell of origin of cancer.
To further investigate the differentiation states present within the luminal lineage in the PyMT tumours, we performed pseudotime analysis using Monocle (Fig.   4 ). We used the mammary gland hierarchy gene signature 44 to build the pseudotime structure of the PyMT cancer epithelial cells identifying 7 discrete states (Fig. 4A ).
Consistent with previous results, ELF5 had a profound impact upon the structure of the epithelial cell diversity biasing the composition of the cells towards one of the right axes of the pesudotime plot (dominated by state 7) at the expense of a depletion of states 2, 4, 5 and 6. We then visualised the Monocle defined cell states using the coordinates from the tSNE (Fig. 4B ) which allowed us to overlap the cell cluster identity defined in Figure 3 with the pseudotiming states from retains most of the cell diversity and strong plasticity, a basal/myoepithelial compartment and a hormone-sensing lineage (Fig. 4G ).
Molecular mechanisms of cancer progression associated to cancer cells of Alveolar origin.
The functional annotation of the identified epithelial cell clusters, using GSVA, showed the expected functions of the annotated cell types from Figure 4G (Supp. Fig. 7 and Table 1 ). Figure 5A shows the distribution of cell cycle marker signatures 58 in the epithelial cell compartment. These signatures identified a specific group exclusively populated by cells undergoing G2M/S, PyMT/ELF5 tumours showed an enrichment on G1, this is consistent with our previous results of the effects of Elf5 increasing cell cycle times by delaying entry in S phase in cell lines of human breast cancer 37 , and with reduced cell proliferation in PyMT tumours 38 .
We then performed GSVA for specific signatures of known functions of Elf5, and functions suggested by the Hallmark analysis from SupplFig 7, which included lactation, involution, EMT and hypoxia (Fig. 5B ). This analysis revealed strong inductions of lactation, involution, MET and hypoxia associated to Elf5/alveolar tumours ( We have previously shown that PyMT/ELF5 tumours presented extensive vascular leakiness, a fact that can lead to increased hypoxia 38 . Cells enriched for a hypoxic gene signature concentrated in myoepithelial and alveolar cells (Fig. 5D ). We confirmed these findings using hypoxyprobe to identify hypoxic regions in the tumours. Immunohistochemistry showed extensive hypoxic regions in PyMT/ELF5 tumours compared to their WT counterparts, indicating that alveolar cells are strong drivers of events leading to hypoxia or these cells are able to survive better in hypoxic regions. This phenotype was strong enough to induce hypoxia in the metastases of a highly oxygenated tissue such as the lung (Fig. 5D ).
As expected, the lactation signature was strongly enriched in cells of alveolar origin (Fig. 5E , top tSNE plot). Immunohistochemistry using anti-milk antibodies revealed a strong production of milk in PyMT/ELF5 tumours compared to PyMT/WT tumours (Fig. 5E, IHC pictures) . The production of milk in a context where there is no suckling pup or structure of the mammary gland to be able to eject milk, results in the accumulation of milk in PyMT/ELF5 tumours. In the normal mammary gland, milk stasis subsequently generates the signals that trigger mammary involution. In this scenario, we could identify an involution gene signature 59 associated with the luminal lineage in PyMT tumours, specifically enriched in alveolar cells (Fig. 5E , bottom tSNE plot).
High Elf5 expression levels are a poor prognosis factor in luminal breast cancer 38 , thus we asked whether lactation and/or involution signatures could predict for patient survival. We used the METABRIC dataset 60 first to assess the effects of Elf5 expression in breast cancer patents in this cohort. We found a significant association between Elf5 high expression and poorer patient prognosis, and also a consistently higher proportion of TNBC basal subtype in the Elf5-high group (Fig.   5F ), which goes in line with previous reports 37 . We have previously shown the importance of Elf5 in the acquisition of endocrine therapy resistance, thus we next assessed the prognostic value of the involution and lactation signatures in the luminal subtype. Importantly, Elf5 expression, the involution signature (Fig. 5G, top panels) or the lactation signature alone (data not shown) did not have predictive value, however the presence of the involution gene signature in Elf5-high patients was exclusively associated with poor prognosis (Fig. 5G, bottom panels) . The lactation signature combined with Elf5 did not show any significant association (data not shown).
Taken together, single-cell transcriptomics enables the identification of biological properties of mammary tumours and, in particular, the role of mimicry involution associated with the Elf5-alveolar subtype in luminal breast cancer.
Characterisation of cancer-associated fibroblasts in PyMT tumours
The involution process involves cell apoptosis and tissue remodelling, the latter of which is orchestrated by stromal and immune cells 61 . Among these cell types, fibroblasts have a critical role in the extracellular matrix remodelling and immune suppression during involution 62 . Thus, we further explored the role of cancer-associated fibroblasts (CAFs) in aberrant involution in our model. CAFs are known to be highly diverse, which it was confirmed in our system as classical fibroblast markers 63 failed to be specific to our transcriptomically defined clusters (SuppFig. 8D). Previous unbiased scRNAseq analyses in human tumours has classified two major CAF subtypes 64, 65 : activated myofibroblasts, involved in tissue remodelling architecture by physical forces; and secretory CAFs related to ECM synthesis and cyto-and chemokine production 66 . Clusters 0 and 1 were enriched for a secretory CAF signature (CAFs-0 and CAFs-1) while the activated myofibroblast signature was concentrated in Cluster 2 (CAFs-2) ( 
CAFs from Elf5/PyMT mammary tumours show features of mimicry involution.
Mammary involuting fibroblasts have unique properties that include a high production of fibrillar collagen, ECM remodelling and immune suppression trough monocyte recruitment 62 . This specialised class of fibroblast involved in involution are characterised by the expression of Col1a1, Cxcl12, Tgfb1 and Mmp3. Within our
PyMT tumours we identified a group of ECM-CAFs and iCAFs with high expression of these involution markers (Fig. 6E, upper tSNE plot) . These cells were further defined as discrete groups when a higher resolution was applied in the clustering ( demonstrated that such genotype polarisation was not due to batch effects.
Consistently, GSVA of the CAF-involution signature and involution marker genes were significantly enriched in the CAFs from ELF5 tumours compared to the WT (Fig. 6G) .
The functional annotation of the involution fibroblasts revealed specific differences within each ECM-or immune-CAF subpopulations (SuppFig. 9B). For example, the top pathways of the involution ECM-CAFs that were unique of this ECM subgroup, fatty acid metabolism and peroxisome hallmarks, suggested that these cells may correspond to adipocyte-like fibroblasts arisen through a dedifferentiation process of mature adipocytes 68 or transdifferentiation process of activated fibroblasts 69 . Adipocyte-derived fibroblasts secrete fibronectin and collagen I and have invasive properties 68, 70 . Moreover, during the stromal remodelling stage in involution, there is a re-differentiation of the adipocytes 61, 71 . Thus, this involution ECM-CAF population might correspond to highly secretory CAFs that are able to remodel the ECM in a similar way to that which involuting fibroblasts would reorganise the ECM to facilitate the detachment of the apoptotic alveoli and the repopulation of the stroma by adipocytes. Involution iCAFs, on the other hand,
showed pathways linked to a wound-healing process, including inflammation through the complement cascade and coagulation 59, 72, 73 . The late stages of involution share many wound-healing properties such as high immune cell infiltration and immune suppression 74 , thus this involution iCAFs might be responsible for these two immune-related processes.
Our finding on CAFs activation mediated by Elf5-alveolar epithelial cells has never been reported before, thus we performed orthogonal functional validation for the role of CAFs in ECM remodelling by the production of collagen fibres in both
PyMT/WT and PyMT/Elf5 tumours. Second Harmonic Generation (SHG) imaging and picrosirius red staining of tumour sections showed an increase in fibrillar collagen coverage in PyMT/Elf5 tumours compared with their PyMT/WT counterparts ( Fig.   7A and B) . Polarised light microscopy showed that PyMT/Elf5 tumours had a significantly higher proportion of thicker and mature collagen fibres than PyMT/WT tumours (Fig. 7C ). Further analysis of matrix ultrastructure revealed a more complex spatial arrangement (peak alignment (+/-10 degrees from peak)) of collagen fibres in
PyMT/Elf5 tumours than in PyMT/WT tumours ( Fig 7D) . Taken together these results show higher fibroblast activity both in collagen deposition and in their rearrangement in PyMT/Elf5 tumours.
Characterisation of the cell-to-cell interactions involved in the cancer-associated involution mimicry.
Our findings showed that CAFs responded to involution signals presumably originated in the alveolar cancer cell compartment. As the TME is highly complex and there are numerous possible cellular interactions we used our high-resolution single cell RNAseq data to identify networks of cell-to-cell communication in PyMT tumours.
Recently, CellphoneDB was implemented to explore cellular interactions among ensembles of cells from scRNAseq data 45 . CellphoneDB is a manually curated repository of ligand-receptor interacting pairs (www.CellPhoneDB.org) combined with a statistical framework to predict cell-to-cell connections (see Material and Methods). CellphoneDB analysis in PyMT tumours revealed an intricate network of cell interactions, allowing us to define molecular pathways for cell communication in almost all of the cell clusters (Fig. 8) . Figure 8A shows the interactome of all cell clusters defined in this study ( Figure 3 for the epithelial clusters, Figure 6 for the CAFs and Figure 2 for all other clusters). These interactions were ranked from strongest to weakest (Fig 8A, count We then investigated what particular ligand/receptor interactions were found among CAFs, alveolar epithelial and myeloid cells in order to find common pathways linked to involution (Fig. 8C) . Overall, we found pathways associated with the multifunctional aspects of involution (TGFβ axis) 76, 77 ; networks associated with an immune suppressive ecosystem (Cxcl12 and Dpp4 axis) 62, 78 and ECM remodelling (IGF axis) 79 (Fig. 8C) . Transforming growth factor β2 and 3 (TGFβ2 and TGFβ3) are ligands produced by CAFs and the two alveolar epithelial clusters, while their receptor TGFβR3 is exclusively expressed in involution ECM and iCAFs and in iCAFs-1 (Fig. 8C and D) .
The chemokine Cxcl12 is exclusively expressed in the involution iCAFs and two of its known receptors, CXC chemokine receptor 4 (CXCR4) and atypical chemokine receptor 3 (ACKR3 or CXCR7), are expressed in iCAFs-1 and B and T cells, respectively. Dipeptidyl peptidase-4 (Dpp4) was expression was restricted to iCAFs-1 and showed a highly interactive axis; Dpp4 connected with the involution iCAFs through Cxcl12 and with myeloid cells through Cxcl2 and Cxcl10. The IGF1/IGF1R signalling pathway was found to be highly specific to the two involution CAF subtypes, ECM and immune, in which a predicted positive feedback loop among these cells was observed. Of note is that IGF signalling is classically associated with collagen and ECM remodelling in fibroblasts 79 .
We have previously demonstrated that infiltrated myeloid-derived suppressor cells (MDSC) are involved in Elf5-driven lung metastasis in PyMT tumours 38 and our CellphoneDB analysis confirmed a high number of interactive networks of myeloid cells with the rest of the tumour components, therefore suggesting that MDSC might be responsible for some of these interactions. Unfortunately, due to the low number of myeloid cells from our unbiased Drop-seq approach we were unable to further divide the myeloid compartment into their subtypes, especially for the detection of MDSC which is a rare-cell population 80 . However our scRNAseq showed expression of genes from well-known signalling pathways for MDSC expansion, recruitment and malignant activation 81 (Fig. 8D) . In summary, we have found that cells in the TME of PyMT tumours are highly interactive. We have identified a particular functional network in Elf5 tumours involving ECM CAFs, involution iCAFs and alveolar epithelial cells that orchestrate developmental pathways similar to established involution.
Discussion
Here, we study the molecular and cellular events acquired during metastatic progression by alteration of the composition of the mammary epithelium towards the basal epithelial-like TNBC subtype. We use a doxycycline-inducible MMTV-
PyMT/Elf5 mouse model to force the differentiation of the alveolar lineage, simultaneously characterising the composition of the mammary epithelium and the TME during the acquisition of the metastatic phenotype using highly-parallel scRNAseq technology.
Conventional transcriptional analyses have classified PyMT tumours within the luminal subtype of breast cancer 33, 82 , presumably due to the prevalent presence of the luminal progenitor cells; however our scRNAseq analyses reveal a much higher diversity of epithelial cell types which resemble all of the intrinsic subtypes of breast cancer coexisting within each tumour (Fig. 4 ) 13, 17, 21, 44, 55, 83, 84 . For many years, the study of the mammary gland epithelial hierarchy has provided important insights into the cell of origin of the different breast cancer subtypes [32] [33] [34] 82, 85, 86 . Our highresolution analysis has revealed intermediate "states" within the luminal progenitor compartment that show features and some commitment towards a hormone-sensing lineage (epithelial cluster 4), or alveolar lineage (epithelial cluster 2), a quality also found in the normal mammary epithelium 55 . The structure of the mammary epithelial hierarchy has been recently investigated using scRNAseq technology both in mice 44, 55, 84 , and in humans 87 . These studies support the current understanding of the presence of three main epithelial lineages both in mouse and human. Interestingly, a transcriptional definition of a cell type consistent with a stem-cell identity was not achieved, suggesting that the "stem-cell state" is not static and rather is a highly dynamic state within a transcriptional space that is strongly influenced by the cell's niche 88 . These studies however support the bi-progenitor theory 16, 89 as they identify an early basal progenitor, responsible for giving rise to the myoepithelial lineage and a luminal progenitor, which gives rise to the alveolar and hormone sensing lineages.
Thus, our findings underscore the intense plasticity associated with the luminal progenitor population, and supports the current understanding of these transit-amplifying cells as the cell of origin of basal and luminal cancers (reviewed in 32 ) and thus contributing to the inter-tumour heterogeneity.
Our Elf5 transgenic model recapitulates the differentiation of the pregnancy associated alveolar epithelium during tumour progression 7, 22 . Transformed alveolar cells endow tumours with a highly metastatic capacity, typical of the basal TNBC subtype. As a differentiated subtype, cell-intrinsically properties of alveolar tumours would generally indicate better outcomes 90 . Alveolar cells however, are centrally involved in cell-to-cell interactions (Fig. 8.) and orchestrate an intense deregulation of the TME activating metastatic cues, specifically through communication with CAFs and tumour infiltrated myeloid cells. We have previously shown that Elf5-driven alveolar tumours presented enhanced cancer immunotolerance, vascular leakiness and angiogenesis, which in turn produced a dramatic increase of metastasis, similar to that induced by pregnancy 38 . Our scRNAseq study reveals that cells with a transcriptional profile consistent with an alveolar cell identity are present in the wild-type PyMT tumours, although at a very low frequency (1.2%). Nevertheless the blueprint of these cells are highly represented within the LP transcriptional pool, suggesting that tumours are well equipped to stimulate a clonal expansion of alveolar cells upon the right selective conditions. This has profound therapeutic implications, in the clinical setting; patients with luminal tumours receive standard-of-care anti-estrogen therapy.
In this context, an endorsed alveolar fate does represent a route of escape from endocrine therapy, as these cells are insensitive to estrogen 37 , subsequently giving rise to an alveolar (basal) TNBC tumour 37 with much poorer survival rate 38 . As such, Elf5 expression is associated with the Basal subtype 37 , and is a poor prognostic factor in Luminal A breast cancer patients 38 .
Despite reducing a patient's lifetime risk of developing breast cancer 35, [91] [92] [93] , pregnancy has been shown to produce a transitory short-term increased risk in the following 5 years after pregnancy. However, there are still contrasting reports on the protective or non-protective effect of pregnancy in breast cancer, which is due in part to the poor knowledge of the molecular mechanisms involved in pregnancyassociated breast cancer (PABC). Our Elf5 MMTV-PyMT model represents much of the molecular and cellular mechanisms that are induced during pregnancy as we are able to reorganise the mammary gland hierarchy by forcing the differentiation of the alveolar epithelium. The resultant tumours recapitulate many of the features characteristic of PABC 38 , and has been an invaluable model for studying the underlying molecular mechanisms associated with this aggressive type of breast cancer.
Our simultaneous observation of cancer cells and cells from the TME, has allowed us to uncover multicellular mechanism of cancer spread as a consequence of an aberrant mammary involution program. We demonstrate that Elf5 CAFs have remodelling driven by involuting ECM-CAFs (Fig 8E) .
Our scRNAseq analyses have also allowed us to identify putative molecular candidates responsible of this epithelium-fibroblast-myeloid crosstalk during mimicry involution (Fig 8) . For example, we find that only alveolar epithelial cells express TGFβ2 and 3 ligands and their receptor TFGβR3 is expressed in involution CAFs.
TGFβ is linked to tumour malignancy by affecting both cancer cells and the TME, including CAF activation and immune suppression 76 suggesting that this could be a specific pathway driving mimicry involution. In fact, TGFβ3 is induced in response to milk stasis during the first stage of involution for the induction of alveolar apoptosis and TGFβ signalling is also key in the second stages of normal involution for the induction of ECM deposition and immune suppression 77 . Altogether, this suggests that TGFβ signalling might be one of the pivotal pathways triggered by Elf5-alveolar cells and thus a potent pathway to be therapeutically targeted.
We also find specific pathways of crosstalk among involution CAFs, other CAF-types and the tumour-infiltrating immune system, which might be activated following this Elf5-mediated TGFβ activation. These include the expression of Cxcl12 by the involution iCAFs and IGF1 from both ECM and inflammatory involution CAFs. Cxcl12 is a stromal chemokine that attracts leukocytes through Altogether our data illustrates a highly interactive TME, particularly with
CAFs and myeloid cells, with cancer-differentiated cells that are pivotal initiating the events that result in tumour tolerance and metastasis as a consequence of mimicry involution. Our data highlights the relevance of targeting cancer-associated cell species as a strategy for anticancer therapy, an approach particularly important in the context of PABC.
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